Yüklüyor......
Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
OBJECTIVES: To compare clinical outcomes and health care costs across three cohorts of uncontrolled diabetic patients who initiated treatment with one of the following: sulphonylureas (SU), thiazolidinediones (TZD) or sitagliptin (SITA). MATERIALS AND METHODS: We performed a retrospective study base...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4211865/ https://ncbi.nlm.nih.gov/pubmed/25364266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S63666 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|